These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ACE inhibitor effects on platelet function in stages I-II hypertension. Moser L; Callahan KS; Cheung AK; Stoddard GJ; Munger MA J Cardiovasc Pharmacol; 1997 Oct; 30(4):461-7. PubMed ID: 9335405 [TBL] [Abstract][Full Text] [Related]
3. [Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study]. Skowasch D; Lentini S; Andrié R; Jabs A; Bauriedel G Dtsch Med Wochenschr; 2001 Jun; 126(24):707-11. PubMed ID: 11446026 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry. Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854 [TBL] [Abstract][Full Text] [Related]
5. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril. Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590 [TBL] [Abstract][Full Text] [Related]
6. Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension. Gleerup G; Petersen JR; Mehlsen J; Winther K Angiology; 1996 Oct; 47(10):951-5. PubMed ID: 8873580 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets. Harmon S; Inkielewicz-Stepniak I; Jones M; Ledwidge M; Santos-Martinez MJ; Medina C; Radomski MW; Gilmer JF J Pharm Pharmacol; 2012 Jan; 64(1):77-89. PubMed ID: 22150675 [TBL] [Abstract][Full Text] [Related]
8. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor. Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046 [TBL] [Abstract][Full Text] [Related]
9. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. Pu Q; Larouche I; Schiffrin EL Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331 [TBL] [Abstract][Full Text] [Related]
10. Fosinopril: a new generation of angiotensin-converting enzyme inhibitors. Weber MA J Cardiovasc Pharmacol; 1992; 20 Suppl 10():S7-12. PubMed ID: 1283429 [TBL] [Abstract][Full Text] [Related]
11. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension. Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174 [TBL] [Abstract][Full Text] [Related]
12. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension. Wagstaff AJ; Davis R; McTavish D Drugs; 1996 May; 51(5):777-91. PubMed ID: 8861547 [TBL] [Abstract][Full Text] [Related]
13. Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension. Hernández-Hernández R; Armas-Padilla MC; Velasco M; Carvajal AR; Armas de Hernández MJ; Guerrero-Pajuelo J; Pacheco B Int J Clin Pharmacol Ther; 1999 Jul; 37(7):323-31. PubMed ID: 10442506 [TBL] [Abstract][Full Text] [Related]
14. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527 [TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro. Weber AA; Reimann S; Schrör K Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233 [TBL] [Abstract][Full Text] [Related]
16. Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients. Hansson L; Forslund T; Höglund C; Istad H; Lederballe-Pedersen O; Kristinsson A; Segaard E; Svensson A; Aärynen M; Wahrenberg H; Wennersten G; Kjellström T J Cardiovasc Pharmacol; 1996 Jul; 28(1):1-5. PubMed ID: 8797128 [TBL] [Abstract][Full Text] [Related]
17. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP. Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543 [TBL] [Abstract][Full Text] [Related]
18. In-vitro and ex-vivo inhibition of blood platelet aggregation by naftazone. Durand P; Bloy C; Peltier-Pujol F; Blache D J Pharm Pharmacol; 1996 Jun; 48(6):566-72. PubMed ID: 8832488 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of H2-receptor antagonists on platelet function in vitro. Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360 [TBL] [Abstract][Full Text] [Related]
20. The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro study. Hernandez Hernandez R; Carvajal AR; Guerrero Pajuelo J; Armas de Hernandez MJ; Armas Padilla MC; Barragan O; Boada Boada JJ; Roa E Am Heart J; 1991 Jan; 121(1 Pt 2):389-94. PubMed ID: 1824665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]